Ain Medicare Sdn Bhd

1.      Introduction

1.1)   Company profile

AIN MEDICARE SDN BHD (AMSB) that was established in 1993 is a trusted name and leading manufacturer of pharmaceutical products, ranging from Large Volume Parenterals, Small Volume Parenterals, Irrigation Solutions, Haemodialysis Concentrates and Peritoneal Dialysis Solutions.

Located in Kelantan, on the East Coast of Peninsular Malaysia, the company operates from a multi-million dollar state-of-the-art pharmaceutical complex. The complex, inaugurated by former Prime Minister Tun Dr. Mahathir Mohamad in 1997, is fully equipped with production floor, microbiological and chemical laboratories, warehouse and administrative centre.

Picture 1: Tun Dr Mahathir during AMSB opening ceremony

A wholly-Malaysian owned company, AIN MEDICARE SDN BHD is helmed by the Chairman, Dato' Wan Ariff Bin Wan Hamzah and Chief Executive Officer, Dr. Syed Ibrahim Bin Mohd. Ismail. Over the years, this far-sighted leadership and strategic management system has successfully steered the company towards numerous remarkable achievements. Today, AIN MEDICARE SDN BHD's authorized share capital stood at RM 20 million with paid up share capital of RM 20 million.

AIN MEDICARE SDN BHD's products have gained international acceptance and are used by private and public health care sectors as well as non-profit healthcare providers in Malaysia and abroad benefiting millions of people across the globe.

1.2)   Company Vision

To further innovate superior quality healthcare products to the highest standard and to provide outstanding customer services worldwide.

1.3)   Company Mission

AMSB is committed to provide reliable and quality products and services that consistently meet the satisfaction of health professionals and patients, in compliance with regulatory requirements and best practices.

2.      Nature Of CSR Work Done So Fars

With more than 700 work forces, AIN MEDICARE SDN BHD has produced a range of intravenous solution products, both Large Volume Parentals (LVP) as well as Small Volume Parentals (SVP). Intravenous (IV) solution is a medical solution that administrated directly into human blood vein by using syringe instead of normal human digestion system. Since it is directly injected into human blood vein, the IV solution need to be processed properly to avoid blood contamination which will lead to death. Among IV solution that produced by AMSB are:

                   I.            Sodium Chloride

                II.            Dextrose

             III.            Mannitol

             IV.            Potassium Chloride

Picture 2: AMSB’s IV solution products

Besides, AIN MEDICARE SDN BHD also produced Haemodialysis concentrates and Peritoneal dialysis solutions. Haemodialysis is a method that is used to achieve the extracorporeal removal of waste products such as creatinine and urea and free water from the human blood when the kidneys are in a state of renal failure. On the other hand, Peritoneal dialysis is a treatment for patients with severe chronic kidney disease.

Other than that, by modern and sophisticated technologies such as Blow-Fill and Seal (BFS) machine enables AIN MEDICARE SDN BHD to increase its production capacity to more than 20 million bottles of IV solutions annually. BFS machine is an automatic machine that used to produce IV solution product in plastic bottle.

3.      Social/Environment Impacts Of Their Work

AIN MEDICARE SDN BHD is known as ‘the king’ of intravenous solution manufacturer in Malaysia. They supplied the IV solution products to the both government hospitals as well as private hospital in Malaysia. Moreover, AIN MEDICARE SDN BHD also is a supplier for IV solution product for more than 10 countries such as Thailand, Brunei, Philippines, and Sri Lanka.

Picture 3: AMSB product at hospital

  

4.      Future Plans Of The Company On CRS

Having carved a niche for itself in Malaysia and the region, AIN MEDICARE SDN BHD aims to be a market leader in the international healthcare scene. In order to achieve that, AIN MEDICARE SDN BHD currently are investing more RM 20 million to set up new IV solution’s production line. The investment includes sophisticated machine, building and facilities.

Picture 4: AMSB’s new machine from Germany under testing

5.      Other Relevant Information.

It is not easy to set up a pharmaceutical company since it needs to be certified by regulatory and will have annually inspection. Any pharmaceutical company that doesn’t comply with regulatory, it may end up with license termination. In Malaysia, National Pharmaceutical Control Bureau (NPCB) under Ministry of Health is responsible for pharceutical company certification. AMSB had been certified to current Good Manufacturing Practice (cGMP) by NPCB since 1994.

Other than that, AIN MEDICARE SDN BHD has received other certification from international and local certification organizations such as: 

1.  Certification of Quality Management System to ISO 9001:2008 by Det Norske Veritas (DNV). 
2.  Certification of Environmental Management System to ISO 14001:2004 by Det Norske Veritas (DNV). 
3.  MS ISO/IEC 17025 Certification for Chemical and Microbiological laboratories by the Department of Standards Malaysia.

Source: Compilation from various sources